C A A Cancer Journal for Clinicians 2000: Vol 50 Index

11 Pages·2000·1.7 MB·English

GA CARGCER | <¢ Z2OCUsSEr3S93- 404
INDEX
L
Lillemoe KD, 241-268
B
Bland KI, 171-183 M
Bolden S, 7-11 McGinnis LS, 171-183
Bruera E, 68-69 (Guest Editorial) Mettlin CJ, 34-49
Burton RC, 209-213 (Guest Editorial) Morrow M, 171-183
Byock I, 123-132 Murray T, 7-11
Cc N
Cameron JL, 241-268 Nadir B, 380-393
Carucci JA, 215-236
Cherny NI, 70-116
P
D Petrek JA, 292-307
Pressman PI, 292-307
Davis KJ, 34-49
Dignam JJ, 50-64
R
E Ragde H, 380-393
Rigel DS, 215-236
Elgamal A-A, 380-393 Roach, M III, 344-347(Guest Editorial)
Engstrom PF, 140-142 (Guest Editorial)
Eyre HJ, 34-49, 171-183
S
G Seffrin JR, 4-5 (Guest Editorial), 121-122, 135
Smith RA, 34-49, 292-307, 312-336
Giuliano AE, 279-291 Stewart AK, 171-183
Goldschmidt RA, 184-200
Grado GL, 380-393 Vv
Greenlee RT, 7-11
Vogel VG, 156-170
H
Ww
Hanks GE, 349-375
Hansen N, 279-291 Winchester DP, 184-200
Horwitz EM, 349-375 Wingo PA, 7-11
Hsueh EC, 279-291 Woolam GL, 6, 121-122, 276-278 (Guest
Hughes JR, 143-151 Editorial)
Y
J
Jeske JM, 184-200 Yeo CJ, 241-268
K
Kelly JR, 121-122
VOL. 50 NO. 6 NOVEMBER/DECEMBER 2000
Subjects American Cancer Society Acknowledgment 2000,
394
American Cancer Society Continuing Medical
A Education activity, 11
Breast cancer, adjuvant therapy for, NIH
Addiction Consensus Development Conference, 214
Opioid analgesics, 93-94 New Editors for CA, 135
Adjuvant therapies Volunteers sought for osteosarcoma and lym-
Prostate cancer, external beam radiation therapy, phoma vaccine studies, 236
358-365 Antibiotic therapy
Adverse effects management Pain management, 72
External beam radiation therapy, 368 Anticonvulsant drugs
Opioid analgesics, 88-94 Adjuvant analgesics, neuropathic pain, 99-100
Age-creep hypothesis Antidepressants
Breast cancer screening, under age 50, 321-322 Adjuvant analgesics, neuropathic pain, 97-98
Age level Anti-inflammatory drugs
Breast cancer screening, under age 50, 314-317, Adjuvant analgesics, bone pain, 100
319
Cancer statistics, incidence, females, 18 Atypia
Cancer statistics, incidence, gender differences, 17 Hyperplasia with, fine needle aspiration biopsy,
Cancer statistics, incidence, males, 19 technique improvements, 272 (News & Views)
Cancer statistics, mortality rates, females and Axillary lymph node dissection. See also Sentinel
sites, 26 lymph node dissection
Cancer statistics, mortality rates, global, 32-33 Breast cancer, 279-280, 286, 287, 288
Cancer statistics, mortality rates, males and
sites, 27 B
Cancer statistics, mortality rates and gender differ-
ences, 20-21, 23 Baclofen
Malignant melanoma, 210-211 (Guest Editorial) Adjuvant analgesics, neuropathic pain, 100
Pap test, increased use urged for older and minor- Benzodiazepines
ity women, 205-206 (News & Views) Adjuvant analgesics, multipurpose, 97
Skin cancer, teenagers, 206 (News & Views) Biological agents
Alcohol consumption Malignant melanoma, 212 (Guest Editorial),
Breast cancer prevention, 165-166 230-231
Alternative cancer treatments Bisphosphonates
American Cancer Society publication on, 207 Adjuvant analgesics, bone pain, 100-101
(News & Views) Brachytherapy. See Prostate cancer brachytherapy
American Cancer Society. See also Continuing Breast cancer. See also Ductal carcinoma in-situ;
Medical Education Activity Lymphedema; Sentinel lymph node dissection
Acknowledgment 2000, 394
(breast cancer)
Breast cancer screening, under age 50, 314
Adjuvant therapy for, NIH Consensus
Clinical trials, encouraging participation in,
Development Conference, 214
3C4o0l-o3r4e3c ta(lN ecwasn ce&r , Viaewwasr)e ness encouraged by, 66 American Cancer Society early detection guide-
lines, 37-38, 47
(News & Views) Cancer Prevention: From Concept to Practice,
Continuing Medical Education activity, 11
140-142 (Guest Editorial)
Early detection guidelines, 34-49
Cancer statistics, race differences and prognosis
Lymphedema, workshop and conference on, 293,
in, 50-64
303-304 Ductai carcinoma in-situ, 184-200
New Editors for CA, 135
Fine needle aspiration biopsy, technique improve-
Professional opportunities with, 208 ments, 271-272 (News & Views)
Publications of, 207 (News & Views)
Lymphedema, 292-311
American Society of Clinical Oncology National Cancer Data Base, clinical highlights,
Reports from 36th annual meeting of, 203-205 174-175
(News & Views) Sentinel lymph node dissection, 279-291
Analgesic pharmacotherapy. See also Pain Surgical management, advances in, 276-278
management (Guest Editorial)
Pain management, 72-75 Tamoxifen and raloxifene, STAR trial, first-year
Announcements recruitment efforts, 271-272 (News & Views)
American Cancer Society, professional opportuni- Breast cancer prevention, 156-170
ties with, 208 Alcohol consumption, 165-166
CA—A CANCER JOURNAL FOR CLINICIANS
CA CANCER 2CGC0:03 9+335>40 4
Approaches to, 158-159 Incidence, females and age level, 18
Chemoprevention, 159-164 Incidence, gender differences, 12, 16
Cigarette smoking, 165 Incidence, gender differences and age level, 17
Diet, 164-165 Incidence, geography, 14
Exercise, 166 Incidence, males and age level, 19
Hormone use, 166-167 Incidence, race, ethnicity, and sites, 24
Lifestyle modification, 164 Incidence, race and stage of diagnosis, 28
Obesity, 165 Limitations and challenges, 10-11
Radiation exposure, 167 Methods, 7-8
Risk assessment model, 157-158 Mortality rates, 8, 9
Surgical risk reduction, 164 Mortality rates, females, sites, and age level, 26
Breast cancer screening (below age 50), 312-336 Mortality rates, females and sites, 23
Background, 313-314 Mortality rates, gender differences, 13, 16
Cost-effectiveness, 327-330 Mortality rates, gender differences and age level,
20-21
Decision making, 314
Disease burden, 314-317 Mortality rates, geography, 15
Early intervention, efficacy of, 317-319 Mortality rates, global and age level, 32-33
Efficacy of, 319-323 Mortality rates, males, sites, and age level, 27
Overview, 312 Mortality rates, males and sites, 23
Performance value, benefit and risk, 323-327 Mortality rates, race, ethnicity, and sites, 24
Summarized, 330-332 Mortality rates, U.S., 22
Mortality rates, U.S., childhood, 30
Survival rates, childhood cancer, 31
€ Survival rates, race and stage of diagnosis, 29
Calcitonin Survival rates, race and year of diagnosis, 25
Adjuvant analgesics, bone pain, 101 2000, 7-11
Adjuvant analgesics, neuropathic pain, 100 Cancer survivors
Cancer Genetic counseling, emotional distress associated
Public misconceptions about, poll results, 138 with, 273 (News & Views)
(News & Views) Capsaicin
Cancer care. See also Palliative care Adjuvant analgesics, neuropathic pain, 98-99
Family caregivers, 67 (News & Views) Caregivers
Home care, American Cancer Society on, 207 Home care, American Cancer Society publication
(News & Views) on, 207 (News & Views)
Cancer pain management. See Pain management Celiac plexus block
Cancer prevention Pain management, 102-103
Breast cancer, chemoprevention, 159-164 Central nervous system side effects
Cancer Prevention: From Concept to Practice, Opioid analgesics, 90-92
140-142 (Guest Editorial) Cervical cancer
Lymphedema, 298-299 American Cancer Society early detection guide-
Malignant melanoma, 216-219 lines, 38-41, 47
Palliative care, 69 (Guest Editorial) Pap test, increased use urged for older and minor-
Cancer screening ity women, 205-206 (News & Views)
American Cancer Society early detection guide- Chemoprevention. See also Cancer prevention
lines, 45-47 Breast cancer, 159-164
Breast cancer, 312-336 Chemotherapy
Breast cancer, race differences and prognosis in, Breast cancer, race differences and prognosis in,
55-56 59-60
Colorectal cancer screening guidelines, 136—137 Malignant melanoma, 229-230
(News & Views) Pain management, 72
Genetic counseling, emotional distress associated Pancreatic cancer, 258-260, 263
with, 273 (News & Views) Childhood cancer
Pap test, increased use urged for older and minor- Statistics, survival rates, 31
ity women, 205-206 (News & Views) Statistics, trends, 10
Cancer statistics Cholecystokinin
Benchmark for the New Century, 6 Pancreatic cancer, 263
Breast cancer, 314-317, 319 Chronic lymphocytic leukemia
Breast cancer, race differences and prognosis in, National Cancer Data Base, clinical highlights,
50-64 173
Childhood cancer, 10 Cigarette smoking
Endgame for cancer, 4-5 (Guest Editorial) Breast cancer prevention, 165
Incidence, 8 Lung cancer, 2 (News & Views)
Incidence, ethnicity, 10
VOL. 50 NO. 6 NOVEMBER/DECEMBER 2000
Pancreatic cancer risk, 243 D
Cigar smoking
Delirium
Lung cancer risk increased five-fold by, 138-139
Opioid analgesics, 90-92
(News & Views)
Dependence
Cingulotomy
Opioid analgesics, 93-94
Pain management, 107
Dextropropoxyphene
Clinical trials
Encouraging participation in, 340-343 (News & Pain management, 77
Diabetes
Views)
Expense of, American Society of Clinical Pancreatic cancer risk, 242-243
Oncology report, 203 (News & Views) Diet
Clonidine Breast cancer prevention, 164-165
Adjuvant analgesics, neuropathic pain, 98 Dihydrocodeine
Smoking cessation, new treatments, 149 Pain management, 76
Codeine Ductal carcinoma in-situ, 184-200. See also
Pain management, 76 Breast cancer
Colonoscopy Classification of, 190-191
American Cancer Society early detection guide- Follow-up surveillance, 199
lines, 43-44 Grading of, 191-193
Colorectal cancer Mammography, 186-187
American Cancer Society early detection guide- Overview, 184-186
lines, 42-44, 47 Pathologic considerations in, 189
American Cancer Society encourages awareness Stereotactic needle core biopsy, 187-188
of, 66 (News & Views) Surgical excision, lesions requiring, 188-189
Cancer Prevention: From Concept to Practice, Treatment, 194-199
141-142 (Guest Editorial) Treatment, local recurrence, management of,
Screening guidelines, 136-137 (News & Views) 198-199
Treatment, local recurrence, predictive factors,
Comedo ductal carcinoma in-situ, 190
194-195
Complementary cancer treatments Treatment, options in, 195-197
American Cancer Society publication on, 207 Treatment, patterns of care, 197-198
(News & Views) Treatment, tamoxifen, 197
Complex decongestive therapy (CDP)
Lymphedema treatment, 299-301
Computed tomography (CT). See also Magnetic E
resonance imaging (MRI); Positron emission Early detection
tomography (PET) American Cancer Society guidelines, 34-49
Lung cancer, 2 (News & Views) Breast cancer screening, under age 50, 317-319
Lung cancer, American Cancer Society early Lung cancer, 2 (News & Views)
detection guidelines, 45-46 Malignant melanoma, 219-220, 222, 227
Lymphedema, 295 Editorials
Pancreatic cancer, 249-254 Breast cancer, surgical management, advances in,
Confusion 276-278 (Guest Editorial)
Opioid analgesics, 90-92 Cancer Prevention: From Concept to Practice,
Constipation 140-142 (Guest Editorial)
Opioid analgesics, 88 Endgame for cancer, 4-5 (Guest Editorial)
Continuing Medical Education Activity External beam radiation therapy and prostate
American Cancer Society, 11 cancer brachytherapy compared, 344-347 (Guest
External beam radiation therapy, 376-379 Editorial)
Lymphedema, 308-311 Malignant melanoma, 209-213 (Guest Editorial)
Malignant melanoma, 237-240 Palliative Care, 68-69 (Guest Editorial)
Pain management, 117-120 Elastic garments
Smoking cessation, 152-155 Lymphedema treatment, 301
Cordotomy Elective lymph node dissection
Pain management, 106-107 Malignant melanoma, 227-229
Corticosteroids Elevation
Adjuvant analgesics, multipurpose, 95-97 Lymphedema treatment, 301
Costs Emotional distress
Breast cancer screening, under age 50, 327-330 Genetic counseling and, 273 (News & Views)
Cribriform ductal carcinoma in-situ, 191 Endoscopic retrograde cholangiopancreatography
Pancreatic cancer, 250
CA—A CANCER JOURNAL FOR CLINICIANS
CA CANCER J CLIN
Endoscopic ultrasound American Cancer Society early detection guide-
Pancreatic cancer, 252 lines, 42-43
Environment Fentanyl
Pancreatic cancer risk, 243-244 Pain management, 79-80
Epidemiology. See also Cancer statistics; Risk Fine needle aspiration biopsy
factors technique improvements, 271-272 (News &
Estrogen levels Views)
Breast cancer risk factors, 157 Flexible sigmoidoscopy
Ethnic differences in cancer statistics American Cancer Society early detection guide-
Breast cancer, race differences and prognosis in, lines, 43
50-64
Colorectal cancer screening guidelines, 136-137 G
(News & Views)
Incidence, race, ethnicity, and sites, 24 Gastric carcinoma
Incidence, race and stage of diagnosis, 28 National Cancer Data Base, clinical highlights,
Mortality rates, race, ethnicity, and sites, 24 176
Pap test, increased use urged for older and minor- Gastrin
ity women, 205-206 (News & Views) Pancreatic cancer, 263
Survival rates, race and stage of diagnosis, 29 Gastrointestinal side effects
Survival rates, race and year of diagnosis, 25 Opioid analgesics, 88-90
trends, 10 Prostate cancer, external beam radiation therapy,
Exercise 518-521
Breast cancer prevention, 166 Gender differences in cancer statistics
External beam radiation therapy, 349-375. Colorectal cancer screening guidelines, 136-137
Adjuvant hormones and radiation therapy, 358- (News & Views)
365 Incidence, 16
Adjuvant hormones and radiation therapy, Incidence, females and age level, 18
EORTC trials, 361-363 Incidence, females and sites, 23
Adjuvant hormones and radiation therapy, Incidence, gender differences and age level, 17
RTOG trials, current, 363-365 Incidence, males and age level, 19
Adjuvant hormones and radiation therapy, Incidence, males and sites, 23
RTOG trials, 1970's, 361 Malignant melanoma, 210-211 (Guest Editorial)
Adjuvant hormones and radiation therapy, Mortality rates, 13, 16
Swedish trial, 363 Mortality rates, females and sites, 26
Continuing Medical Education Activity, 376-379 Mortality rates, gender differences and age level,
Particle beam therapy, 365, 366 20-21
Prognostic models, 369,370 Mortality rates, males and sites, 27
Prostate cancer brachytherapy compared, 350, Gene therapy
340-343 (Guest Editorial) Malignant melanoma, 231-232
Prostate specific antigen test, 349-350 Pancreatic cancer, 263
Results, conventional therapy, 352-354 Genetic counseling
Results, 3DCRT, 354-358 Emotional distress associated with, 273 (News &
Techniques, conventional therapy, 351 Views)
Techniques, three-dimensional conformal therapy, Genetics
350,352 Breast cancer prevention, 162-163
Techniques, three-dimensional conformal therapy, Pancreatic cancer, 245-247
variations, 352
Genitourinary side effects. See also Urinary
Toxicity, 366-369
retention
Prostate cancer, external beam radiation therapy,
F 366-369
Global cancer statistics
False-negative results
Mortality rates, global and age level, 32-33
Sentinel lymph node dissection, 280-281
Global perspective
False-positive results
World Oncology Camp, 66 (News & Views)
Breast cancer screening, under age 50, 326-327
Growth factors
Family caregivers
Pancreatic cancer, 247-248
Strength for Caring program, 67 (News & Views)
Fatigue
Management of treatment-related, 274-275 (News H
& Views)
Head and neck cancers
Fecal occult blood test
National Cancer Data Base, clinical highlights, 177
VOL. SO NO. 6 NOVEMBER/DECEMBER 2000 399
HIV infection. See Human immunodeficiency Lung cancer, American Cancer Society early
virus (HIV) detection guidelines, 45-46
Home cancer care Lumpectomy
American Cancer Society publication on, 207 Breast cancer, race differences and prognosis in,
(News & Views) 58-59
Hormones Ductal carcinoma in-situ, 196
Breast cancer prevention, 166-167 Lung cancer
Hormone therapy American Cancer Society early detection guide-
Pancreatic cancer, 263 lines, 45-46
Prostate cancer, external beam radiation adjuvant Cancer Prevention: From Concept to Practice,
therapy, 358-365 141 (Guest Editorial)
Hospice care Cigar smoking increases risk five-fold, 138-139
Palliative care, 69 (Guest Editorial), 126-129 (News & Views)
Invisible cancer, 2 (News & Views)
Hydrocodone
National Cancer Data Base, clinical highlights,
Pain management, 77 179
Hydromorphone
Lymphedema, 292-311. See also Breast cancer
Pain management, 79
American Cancer Society workshop and confer-
Hyperplasia
ence, 293, 303-304
Atypia with, fine needle aspiration biopsy, tech- Anatomy and physiopathology of, 293-294
nique improvements, 272 (News & Views) Assessment of, 294-295
Breast cancer, surgical management, advances in,
277-278 (Guest Editorial)
Continuing Medical Education Activity, 308-311
Immunotherapy Etiology of, 295, 297-298
Malignant melanoma, 212 (Guest Editorial), 231 Incidence of, 295, 296
Impotence. See also Genitourinary side effects Overview, 292-293
Prostate cancer brachytherapy, 387-388 Presentation and progression of, 294
Interferon alpha 2b Prevention of, 298-299
Malignant melanoma, 230 Treatment of, 299-302
Interferon gamma Lymph node dissection
Malignant melanoma, 230 Malignant melanoma, 211-212 (Guest Editorial),
Interleukin-2 227-229
Malignant melanoma, 230 Lymph node metastasi
Internet services Pancreatic cancer, 245
Spanish language, 67 (News & Views) Lymphocytic leukemia, chronic
Intraoperative lymphatic mapping, 279-291. See National Cancer Data Base, clinical highlights,
also Sentinel lymph node dissection 173
Invisible cancer Lymphoma
Lung cancer, 2 (News & Views) Volunteers sought for osteosarcoma and lym-
phoma vaccine studies, 236
L
M
Leukemia, chronic lymphocytic
National Cancer Data Base, clinical highlights, Magnetic resonance imaging (MRI). See also
173 Computed tomography (CT); Positron emission
Levorphanol tomography (PET)
Pain management, 80 Lymphedema, 295
Life-prolongation. See also Palliative care Pancreatic cancer, 250
Palliative care and, 123-132 Malignant melanoma, 215-240
Lifestyle modification Clinical examination, 222
Breast cancer prevention, 164 Continuing Medical Education Activity, 237-240
Diagnosis, 221-222
Liver cancer
Diagnosis, early, 219-220, 222, 227
National Cancer Data Base, clinical highlights,
178 Overview, 215-216
Self-examination, 222-227
Liver disease Sun protection, 218-219
Pain management, opioid selection, 81 Treatment, 227-232
Liver metastasis
Malignant melanoma (Australia), 209-213 (Guest
Pancreatic cancer, 245
Editorial). See also Melanoma
Low-dose spiral computerized tomography
Age level and gender differences, 210-211 (Guest
Lung cancer, 2 (News & Views) Editorial)
400 CA—A CANCER JOURNAL FOR CLINICIANS
2000:356: 3 5-404
Australia, 209 (Guest Editorial) Testicular carcinoma, 182
Biologic therapies and vaccines, 212 (Guest Vulvar melanoma, 182
Editorial) National Cancer Institute
Clinical detection of, 211 (Guest Editorial) Breast cancer, adjuvant therapy for, NIH
Radiotherapy, 212 (Guest Editorial) Consensus Development Conference, 214
Sun exposure levels, 209-210 (Guest Editorial) Breast cancer screening, under age 50, 313-314
Sunscreen vs. sun protection, 210 (Guest Volunteers sought for osteosarcoma and
Editorial) lymphoma vaccine studies, 236
Surgical margins and lymph node dissection, National Institutes of Health
211-212 (Guest Editorial) Breast cancer, adjuvant therapy for, NIH
Mammography. See also Breast cancer screening Consensus Development Conference, 214
(below age 50) Breast cancer screening, under age 50, 313-314
Ductal carcinoma in-situ, 186-187 Nausea and vomiting
Mastectomy Opioid analgesics, 88-89
Breast cancer, race differences and prognosis in, Neuroablative techniques
58-59 Pain management, 105-107
Ductal carcinoma in-situ, 195-196 Neuroleptics
Melanoma. See also Malignant melanoma Adjuvant analgesics, multipurpose, 97
Skin Cancer Awareness Month, 137-138 (News & Neurolysis
Views) Pain management, 106
Vulvar, National Cancer Data Base, clinical high- Nicotine replacement therapy
lights, 182 Smoking cessation, new treatments, 143-151
Menarche N-methyl-D-aspartate (NMDA)
Breast cancer risk factors, 156-157 Adjuvant analgesics, neuropathic pain, 100
Menopause Non-opioid analgesics
Breast cancer risk factors, 156-157
Pain management, 73-75
Meperidine Nutrition
Pain management, 79 Pancreatic cancer risk, 243-244
Metastatic disease
Pancreatic cancer,
Sentinel lymph node dissection, 286-287 Oo
Methadone Obesity
Pain management, 80 Breast cancer prevention, 165
Micropapillary ductal carcinoma in-situ, 190-191 Opioid analgesics, 75-95
Morphine Adverse effects management, 88-94
Pain management, 77-79, 87 Dose selection and titration, 86-88
Multifocal myoclonus General principles, 76
Opioid analgesics, 92 Opioid agonists, listed, 76-80
Multiple myeloma refractory pain, 94-95
Thalidomide treatment, 3 (News & Views) Route of administration, 82-84
Murphy, Gerald P. Scheduling, 84-86
Acknowledgment of, 394 Selection of, 80-82
Dedication to, 380 Oral local anesthetics
Tribute to, 121-122 Adjuvant analgesics, neuropathic pain, 98
Osteosarcoma
Volunteers sought for osteosarcoma and lym-
N
phoma vaccine studies, 236
National Cancer Data Base, clinical highlights, Oxycodone
171-183 Pain management, 77
Breast cancer, 174-175 Oxymorphone
Chronic lymphocytic leukemia, 173 Pain management, 80
Data scope, 172-173
Data sources, 172
Gastric carcinoma, 176 P
Head and neck cancers, 177 Pain management, 7(0—120
Liver cancer, 178 Adjuvant analgesics, bone pain, 100-101
Lung cancer, 179 Adjuvant analgesics, multipurpose, 95-97
Overview, 171-172 Adjuvant analgesics, neuropathic pain, 97-100
Parathyroid carcinoma, 178 Adjuvant analgesics, visceral pain, 101
Prostate cancer, 180 Analgesic pharmacotherapy, systemic, 72-75
Small bowel carcinoma, 181
VOL. SO NO. 6 NOVEMBER/DECEMBER 2000
INDE X
Anesthetic and neurosurgical techniques, 102-103 Pethedine
Anesthetic techniques, 105 Pain management, 79
Continuing Medical Education Activity, 117-120 Pharmacology. See also Pain management
Neuroablative techniques, 105-107 Expense of, American Society of Clinical
Opioid analgesics, 75-95 Oncology report, 203-205 (News & Views)
Opioid analgesics, adverse effects management, Lymphedema treatment, 302
88-94 Tamoxifen and raloxifene, STAR trial, first-year
Opioid analgesics, dose selection and titration, recruitment efforts, 271-272 (News & Views)
86-88 Photoprotection. See Sun protection
Opioid analgesics, general principles, 76 Physiatric therapies
Opioid analgesics, opioid agonists, listed, 76-80 Pain management, 102
Opioid analgesics, refractory pain, 94-95
Pimozide
Opioid analgesics, routes of administration, 82-84
Adjuvant analgesics, neuropathic pain, 100
Opioid analgesics, scheduling, 84-86
Opioid analgesics, selection of, 80-82 Pituitary ablation
Overview, 70-71 Pain management, 107
Palliative care, 68-69 (Guest Editorial), 125-126 Pneumatic pumps
Pancreatic cancer, 262-263 Lymphedema treatment, 301-302
Physiatric therapies, 102 Polymerase chain reaction (PCR)
Primary therapy, 71-72 Malignant melanoma, 229
Psychological therapies, 102 Positron emission tomography (PET). See also
Regional analgesia, 103-105 Computed tomography (CT); Magnetic resonance
Sedation, 107-108 imaging (MRI)
Transcutaneous electrical nerve stimulation, 102 Pregnancy
Palliative care, 68-69 (Guest Editorial), 123-132 Breast cancer risk factors, 157
Hospice care, 126-129
Prevention. See Breast cancer prevention; Cancer
Life-prolonging care integrated with, 129-130
prevention
Mixed-management model, 130
Overview, 123-124 Primary lymphedema, 293. See also Lymphedema
Pain management, 125-126 Probe-directed intraoperative mapping
Pancreatic cancer, 260-263 Sentinel lymph node dissection, 282-283
Pancreatic cancer, 241-268 Propoxyphene
Chemotherapy, 263 Pain management, 77
Diagnosis and staging, 248-253 Prostate cancer
Epidemiology and risk factors, 241-244 American Cancer Society early detection guide-
Gene therapy and vaccines, 264 lines, 41-42, 47
Growth factors, 247-248 National Cancer Data Base, clinical highlights,
Hormone therapy, 263 180
Molecular genetics, 245-247 Statistics, 7-8
Neoadjuvant and adjuvant therapy, 258-260 Vasectomy and risk of, 3 (News & Views)
Overview, 241 Prostate cancer brachytherapy, 380-393.
Palliative care, 260-263 Discussion, 388-392
Pathology, 244-245 External beam radiation therapy compared,
Radiation therapy, 263 344-347 (Guest Editorial)
Resection, 254-258 History of, 381-382
Resection, methods, 254-256 National Cancer Data Base, clinical highlights,
Resection, nonoperative palliation compared, 180
261-262 Overview, 380-381
Resection, results, 256-257 Results of 12-year experience, 387-388
Resection, survival rates, 257-258 Technique, 383
Pancreatitis Technique, high-dose rate brachytherapy, 383
Pancreatic cancer risk, 242-243 Technique, intraoperative seed placement, 386
Papillary ductal carcinoma in-situ, 191 Technique, quality evaluation, 386
Pap test. See also Cervical cancer Prostate specific antigen (PSA) test
Increased use urged for older and minority External beam radiation therapy, 349-350
women, 205-206 (News & Views) Prostate cancer brachytherapy, 388-392
Parathyroid carcinoma Psychological therapies
National Cancer Data Base, clinical highlights, Pain management, 102
178 Psychosocial therapy
Particle beam therapy. See also External beam Smoking cessation, new treatments, 149
radiation therapy Pulmonary edema
External beam radiation therapy, 365-366 Opioid analgesics, 92-93
402 CA—A CANCER JOURNAL FOR CLINICIANS
CA CANCER |} CLIN 20606:50:395-4064
(Guest Editorial)
Surgical techniques, 283-286
Radiation exposure
Sigmoidoscopy
Breast cancer prevention, 167
American Cancer Society early detection guide-
Radiation therapy. See also Prostate cancer lines, 43
brachytherapy
Skin cancer. See also Malignant melanoma;
Breast cancer, race differences and prognosis in,
58-59 Melanoma
Malignant melanoma, 209-213 (Guest Editorial)
Ductal carcinoma in-situ, 195—196
External beam, prostate cancer brachytherapy Skin Cancer Awareness Month, 137-138 (News &
Views)
compared, 344-347
Teenagers and sun protection, 206 (News &
Lymphedema, 297
Views)
Malignant melanoma, 212 (Guest Editorial)
Pain management, 72 Small bowel carcinoma
Pancreatic cancer, 258-260, 263 National Cancer Data Base, clinical highlights,
Radical mastectomy 181
Breast cancer, race differences and prognosis in, Smoking cessation
58 Cancer Prevention: From Concept to Practice,
Radiographic studies. See also Computed tomog- 140-142 (Guest Editorial)
Continuing Medical Education Activity, 152-155
raphy (CT); Magnetic resonance imaging (MRI);
New treatments for, 143-155
Positron emission tomography (PET)
Socioeconomic factors
American Cancer Society early detection guide-
Breast cancer, race differences and prognosis in,
lines, 43
56-57
Radiopharmaceuticals
Solid ductal carcinoma in-situ, 191
Adjuvant analgesics, bone pain, 101
Spanish language
Raloxifene
Internet services, 67 (News & Views)
Breast cancer prevention, 162-163
Tamoxifen and, STAR trial, first-year recruitment Staging. See also Cancer statistics
efforts, 271-272 (News & Views) Pancreatic cancer, 248-253
Renal disease Stereotactic needle core biopsy
Pain management, opioid selection, 82 Ductal carcinoma in-situ, 186-187
Reproductive risk factors Stomach cancer
Breast cancer prevention, 156-157 National Cancer Data Base, clinical highlights,
176
Respiratory depression
Opioid analgesics, 91-92 Sun protection
Malignant melanoma, 210 (Guest Editorial),
Rhizotomy
218-219
Pain management, 105-106
Skin cancer, teenagers, 206 (News & Views)
Risk factors
Surgical management. See also Sentinel lymph
Breast cancer prevention, 156-157
Prostate cancer, vasectomy and, 3 (News & node dissection
Views) Breast cancer, advances in, 276-278 (Guest
Editorial)
Breast cancer, sentinel lymph node dissection,
Ss 279-291
Breast cancer prevention, 164
Screening. See Cancer screening Ductal carcinoma in-situ, 186-187, 195-196
Secondary lymphedema, 293. See also Malignant melanoma, 211-212 (Guest Editorial),
Lymphedema 227
Sedation Pain management, 72, 102-103
Pain management, 107-108 Pancreatic cancer, 254-258
Sentinel lymph node dissection Prostate cancer brachytherapy compared, 402
Lymphedema, 297-298 Survivors
Malignant melanoma, 229 Genetic counseling, emotional distress associated
Sentinel lymph node dissection (breast cancer), with, 273 (News & Views)
279-291. See also Axillary lymph node dissection; Sympathetic blocks
Breast cancer Pain management, 102-103
Development of, 280-283
Histopathologic analysis, 286-287 x
Learning curve in, 287-288
Overview, 279-280 Tamoxifen
Success rate and accuracy, summary table, 284 Breast cancer, race differences and prognosis in,
Surgical management, advances in, 277-278 59-60
VOL. 50 NO. 6 NOVEMBER/DECEMBER 2000
INDEX
Breast cancer prevention, 159-163
Ductal carcinoma in-situ, 196
Raloxifene and, STAR trial, first-year recruitment
efforts, 271-272 (News & Views)
Testicular carcinoma
National Cancer Data Base, clinical highlights,
182
Thalidomide
Multiple myeloma treatment, 3 (News & Views)
Topical local anesthetics
Adjuvant analgesics, multipurpose, 97
Total mastectomy
Breast cancer, race differences and prognosis in,
58-59
Toxicity. See also Adverse effects management
External beam radiation therapy, 366-369
Transcutaneous electrical nerve stimulation
Pain management, 102
U
Ultrasound
Pancreatic cancer, 252
Urinary retention. See also Genitourinary side
effects
Opioid analgesics, 92-93
Prostate cancer brachytherapy, 387
ii cairn iceiaateecscncoceanaiieencniaiace
Vaccines
Malignant melanoma, 212 (Guest Editorial)
Pancreatic cancer, 263
Vasectomy
Prostate cancer risk and, 3 (News & Views)
Vomiting and nausea
Opioid analgesics, 88-89
Vulvar melanoma
National Cancer Data Base, clinical highlights,
182
CA—A CANCER JOURNAL FOR CLINICIANS